Preventing Weight Regain After Glucagon-Like Peptide-1 Therapy Discontinuation: A Pilot Randomized Controlled Trial

Top Things to Know

MTMs may have a role during the transition off GLP-1 RA treatment by providing structured nutrition and reducing meal-planning and food-preparation burden.

The study highlights a potential model in which nutrition support is integrated into obesity treatment around a clinically vulnerable transition point.

Summary of Conclusion/Findings

This pilot randomized controlled trial evaluated whether medically tailored meals (MTMs) or a digital wellness application could support weight maintenance during the first 4 months after discontinuation of glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy among 39 adults who had previously lost more than 10% of body weight with treatment. Participants were randomized to usual care (n=14), the digital wellness application (n=12), or 10 home-delivered MTMs per week (n=13); adherence and satisfaction were the primary outcomes, while weight change was exploratory. Neither intervention significantly differed from usual care for adherence, satisfaction, diet quality or perceived health, although participants assigned MTMs reported consuming an average of 8.08 meals per week. At 4 months, model-estimated weight gain was 10.75% with usual care compared with 3.60% with the wellness application and 3.58% with MTMs; relative to usual care, estimated weight gain was 7.16 percentage points lower with the application (95% CI, −12.27 to −2.04; p=0.007) and 7.17 points lower with MTMs (95% CI, −12.20 to −2.14; p=0.006). Sensitivity analyses adjusting for baseline weight and weight lost during GLP-1 RA treatment attenuated the estimates but continued to show less weight gain in both intervention groups. These weight findings are hypothesis-generating because the small pilot was not powered for definitive efficacy testing, follow-up lasted only 4 months, usual care was not standardized, and the study population was relatively well educated and financially stable, limiting generalizability.